Trial Profile
Phase I trial of CPC 201 in patients with Alzheimer's disease
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 May 2014
Price :
$35
*
At a glance
- Drugs Donepezil/solifenacin (Primary)
- Indications Alzheimer's disease; Dementia
- Focus Adverse reactions
- 19 May 2014 New trial record